Literature DB >> 4358534

Epstein-Barr virus infection in the neonatal period and in childhood.

J Joncas, J Boucher, M Granger-Julien, C Filion.   

Abstract

In an attempt to detect and characterize congenital, neonatal and early childhood EBV infections, a prospective sero-epidemiological study was undertaken in 112 newborn infants and their mothers, 25 additional newborns undergoing exchange transfusion, 114 randomly selected hospitalized infants aged 0 to 3 years, and 109 siblings and parents of these infants. Leukocyte culture was attempted in all the newborns and in 25 pre- and post-transfusion.The findings of EBV seroconversion in six patients without clearly apparent illness, infectious mononucleosis in only one case with significant EBV antibody rise, seroreversion in three cases in early childhood, higher newborn than maternal EBV antibody titres in three cases and the establishment of two permanent lymphoblastoid cell lines from newborns following exchange transfusion raise the possibility of abortive primary EBV infection in early life. Congenital or neonatal infections following exchange transfusions, however, could not be substantiated with certainty since the EBV antibodies did not persist at follow-up except possibly in two cases. Parenteral transmission of the EB virus by exchange transfusion at birth is probably prevented by the presence of EBV antibodies in either donor or recipient.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4358534      PMCID: PMC1947246     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  19 in total

1.  Chromosome preparations of leukocytes cultured from human peripheral blood.

Authors:  P S MOORHEAD; P C NOWELL; W J MELLMAN; D M BATTIPS; D A HUNGERFORD
Journal:  Exp Cell Res       Date:  1960-09       Impact factor: 3.905

2.  Neutralizing activity in human sera against the leukocyte-transforming agent.

Authors:  R S Chang
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

3.  Epstein-Barr virus antibody in cases and contacts of infectious mononucleosis; a family study.

Authors:  F J Nye; H P Lambert
Journal:  J Hyg (Lond)       Date:  1973-03

4.  Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis.

Authors:  G Miller; J C Niederman; L L Andrews
Journal:  N Engl J Med       Date:  1973-02-01       Impact factor: 91.245

5.  Epstein-Barr virus and infectious mononucleosis.

Authors:  W Henle; G Henle
Journal:  N Engl J Med       Date:  1973-02-01       Impact factor: 91.245

6.  IgM antibodies to Epstein-Barr virus in infectious mononucleosis.

Authors:  H Schmitz; M Scherer
Journal:  Arch Gesamte Virusforsch       Date:  1972

Review 7.  Clinical significance of the EB herpesvirus infection in man.

Authors:  J H Joncas
Journal:  Prog Med Virol       Date:  1972

8.  Immunofluorescence in cells derived from Burkitt's lymphoma.

Authors:  G Henle; W Henle
Journal:  J Bacteriol       Date:  1966-03       Impact factor: 3.490

9.  Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis.

Authors:  P Gerber; S Lucas; M Nonoyama; E Perlin; L I Goldstein
Journal:  Lancet       Date:  1972-11-11       Impact factor: 79.321

10.  Epstein-Barr virus-specific IgM in infectious mononucleosis, Burkitt lymphoma, nasopharyngeal carcinoma.

Authors:  J E Banatvala; J M Best; D K Waller
Journal:  Lancet       Date:  1972-06-03       Impact factor: 79.321

View more
  8 in total

1.  EB virus-specific IgA in serum of patients with infectious mononucleosis and of healthy people of different ages.

Authors:  J M Edwards; M Woodroof
Journal:  J Clin Pathol       Date:  1979-10       Impact factor: 3.411

2.  Reduced Transplacental Transfer of a Subset of Epstein-Barr Virus-Specific Antibodies to Neonates of Mothers Infected with Plasmodium falciparum Malaria during Pregnancy.

Authors:  Sidney Ogolla; Ibrahim I Daud; Amolo S Asito; Odada P Sumba; Collins Ouma; John Vulule; Jaap M Middeldorp; Arlene E Dent; Saurabh Mehta; Rosemary Rochford
Journal:  Clin Vaccine Immunol       Date:  2015-09-16

3.  Viral antibodies in maternal and cord sera.

Authors:  T Gotlieb-Stematsky; I Meron; M Modan; Y Sayar; S Leventon-Kriss; A Fogel; R Gurewitz; V Insler
Journal:  Med Microbiol Immunol       Date:  1983       Impact factor: 3.402

4.  Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma.

Authors:  Katherine Cosmopoulos; Michiel Pegtel; Jared Hawkins; Howell Moffett; Carl Novina; Jaap Middeldorp; David A Thorley-Lawson
Journal:  J Virol       Date:  2008-12-17       Impact factor: 5.103

5.  Study of mother-to-child Epstein-Barr virus transmission by means of nested PCRs.

Authors:  M C Meyohas; V Maréchal; N Desire; J Bouillie; J Frottier; J C Nicolas
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

6.  Prolonged meningoencephalitis due to Epstein-Barr virus with favorable outcome in a young infant.

Authors:  R Dagan; E Shahak
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553

7.  Congenital and postnatal CMV and EBV acquisition in HIV-infected Zimbabwean infants.

Authors:  Hlanai Gumbo; Bernard Chasekwa; James A Church; Robert Ntozini; Kuda Mutasa; Jean H Humphrey; Andrew J Prendergast
Journal:  PLoS One       Date:  2014-12-18       Impact factor: 3.240

8.  Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma.

Authors:  A Onnis; M Navari; G Antonicelli; F Morettini; S Mannucci; G De Falco; E Vigorito; L Leoncini
Journal:  Blood Cancer J       Date:  2012-08-31       Impact factor: 11.037

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.